Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients

• Egile Nagusiak: Mikael Koponen (Egilea), Aki S. Havulinna (Egilea), Annukka Marjamaa (Egilea), Annukka M. Tuiskula (Egilea), Veikko Salomaa (Egilea), Päivi J. Laitinen-Forsblom (Egilea), Kirsi Piippo (Egilea), Lauri Toivonen (Egilea), Kimmo Kontula (Egilea), Matti Viitasalo (Egilea), Heikki Swan (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2018-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Long QT syndrome (LQTS) is an inherited cardiac disorder predisposing to sudden cardiac death (SCD). We studied factors affecting the clinical course of genetically confirmed patients, in particular those not receiving β-blocker treatment. In addition, an attempt was made to asso...